The observed high expression levels of GNL1 and RPS20 in various cancer tissues together with our results from the current study suggests the possibility that the co-operation of GNL1 and RPS20 may favor faster cell proliferation during cancer progression and may be an ideal target for cancer therapeutic intervention. This evidence concerns the gene RPS20 and cancer.